Arizona Alternative Cancer Center Publishes New E-Book for Patients
EuroMed Foundation, an Arizona cancer center specializing in non-traditional therapies, has compiled its articles into a new, informative online resource. Phoenix, Arizona (October 2015) — EuroMed Foundation (www.euro-med.us) has published an e-book for patients, their families, and others interested in learning about the services provided by the Arizona alternative cancer center. According to the facility’s lead physicians, the book is…
Breast Cancer Vaccine Shows How Interest in Immune System Is Growing
EuroMed Foundation, an Arizona cancer center, says the development of cancer vaccines increases awareness of the immune system’s role in treatment. Phoenix, Arizona (January 2015) — Physicians at EuroMed Foundation (www.euro-med.us), an Arizona cancer center that promotes holistic treatments, say vaccines that are making headlines lately highlight the immune system’s vital role in successfully treating cancer in a way that…
Breast Cancer Breakthrough Draws Public Eye to Alternative Treatment
Researchers have discovered a new way to treat chemotherapy-resistant breast cancer by exploiting cancer cells’ proclivity for sugar, according to doctors at Arizona cancer center EuroMed who support the rise of treatment alternatives. Phoenix, Arizona (August 2013) — Researchers at the University of Southampton have announced a potential alternative for treating breast cancer that has become resistant to chemotherapy. The…
Advances In Gerontology
Clinical records from individuals followed for 5years, 2000 to 2005, were reviewed. They were distrib-uted in 3 cohorts of ages ranging from 51 to 60, 61to 70, and 71 to 80 years, respectively. Each cohort in-cluded 2 groups of patients with diabetes type 2, onegroup treated with Metformin 850 mg/day, and the otherone without pharmacological treatment. In all groups,for each individual, the mean variation of glycosylatedhemoglobin, ferritin, lymphocyte count, total and sub-populations, was determined in blood using the mea-surement at the beginning and at the end of the 5-yearfollow-up. The number of all living individuals andcancer cases were also recorded in all groups at theend of the 5-year period. The results were consistentwith the reported significance as biomarkers of agingof: the increase of glycosylated hemoglobin and fer-ritin, the decrease of the number of total lymphocytesandCD8+T, and the increase ofT-Regulators. In thispreliminary observation, the protection of Metforminon the variations of aging biomarkers was associatedwith survival and decline of malignancy incidence.
Aging And Social Change
In recent decades, knowledge about the inducing agents of geroprotection and the biomarkersfor measuring geroprotection has allowed scientists to explore their clinical significance andto evaluate their comparative activity.